Antibody Levels Of Health Personnel Post-Booster Vaccination Phase-III
Background: Health workers are one of the groups most at risk of being infected with Covid-19 due to their intense interactions with patients. Therefore, it is necessary to make efforts to increase the endurance of the pandemic by administering vaccines.
Purpose: This study aims to determine the effectiveness of giving phase III booster vaccinations for health workers against increasing Covid-19 antibody titers.
Methode: This study belongs to the type of descriptive quantitative research, the sampling technique is carried out using the slovin formula.
Results: The results showed that constantly (100%), giving booster vaccinations to health workers can increase the effectiveness of the Covid-19 vaccine that has previously been given and is able to strengthen the antibody that has been awakened.
Conclusion: The administration of the phase III booster vaccine can increase the titer of the Covid-19 antibody so that the risk of transmission of the corona virus can be suppressed.
Suggestion: Other puskesmas can carry out phase-III booster vaccinations for health workers as a whole
- Amir, H. (2021). Tenaga Kesehatan di Gowa Mulai Jalani Vaksinasi Booster. sindonews.com, 1–1.
- Arami, M. W., Purnamasari, N., & Rahayu, S. (2022). Jurnal Mahasiswa BK An-Nur : Berbeda , Bermakna , Mulia Volume 8 Nomor 2 Tahun 2022 Tersedia Online : https://ojs.uniska-bjm.ac.id/index.php/AN-NUR ANALISA YANG MEMPENGARUHI KEPUTUSAN TENAGA KESEHATAN MELAKUKAN VAKSINASI COVID-19 DOSIS LANJUTAN ( BOOSTER ) Dipublikasikan Oleh : UPT Publikasi dan Pengelolaan Jurnal Universitas Islam Kalimantan Muhammad Arsyad Al-Banjari Banjarmasin Jurnal Mahasiswa BK An-Nur : Berbeda , Bermakna , Mulia Volume 8 Nomor 2 Tahun 2022 Tersedia Online : https://ojs.uniska-bjm.ac.id/index.php/AN-NUR Dipublikasikan Oleh : UPT Publikasi dan Pengelolaan Jurnal Universitas Islam Kalimantan Muhammad Arsyad Al-Banjari Banjarmasin. 8, 51–54.
- Balaputra STIKes Bhakti Al-Qodiri Program Studi, I. S. (2022). Mewujudkan Masyarakat Sehat dan Produktif dengan Vaksinasi Covid-19 Dosis Lanjutan (Booster). Jurnal Pengabdian Masyarakat Al-Qodiri (JPMA), 1(1), 9–14.
- Banjarnahor, S., Studi, P., & Keperawatan, I. (2021). Analisa Penularan Covid-19 Pada Perawat Di Rumah Sakit. Jurnal Perawat Indonesia, 5(1), 620–628. https://doi.org/10.32584/jpi.v5i1.857
- Bastiana, Wahyu, D., Rachmayanti, N., Pertiwi, M., Biotech, M., & Surya, P. A. (2021). Sosialisasi Vaksinasi Covid-19 dan Pemeriksaan IgG Kuantitatif Pre dan Pasca Vaksinasi Kepada Mahasiswa Magang di RSI Jemursari Surabaya. Seminar Nasional Pengabdian Kepada Masyarakat 2021, 888–896.
- Burckhardt, R. M., Dennehy, J. J., Poon, L. L. M., Saif, L. J., & Enquist, L. W. (2022). Are COVID-19 Vaccine Boosters Needed? The Science behind Boosters. Journal of Virology, 96(3). https://doi.org/10.1128/jvi.01973-21
- Carolina, M., & Agustiani, F. N. (2021). Menjawab Tantangan Pelaksanaan Vaksinasi Covid-19. Buletin APBN, VI(4), 7–10.
- Choudhary, H. R., Parai, D., Dash, G. C., Peter, A., Sahoo, S. K., Pattnaik, M., Rout, U. K., Nanda, R. R., Pati, S., & Bhattacharya, D. (2021). IgG antibody response against nucleocapsid and spike protein post-SARS-CoV-2 infection. Infection, 49(5), 1045–1048. https://doi.org/10.1007/s15010-021-01651-4
- Dinas Kesehatan Surabaya. (2021). Pentingnya Vaksinasi Covid-19. Dinkes.Surakarta.Go.Id. https://dinkes.surakarta.go.id/pentingnya-vaksinasi-covid-19/
- drg. Widyawati, M. (2022). Tambah Regimen Baru Vaksin Booster, Total Ada 6 Jenis Vaksin COVID-19 yang Dipakai di Indonesia. Sehat Negeriku, 1–15. https://sehatnegeriku.kemkes.go.id/baca/rilis-media/20220228/2439416/tambah-regimen-baru-vaksin-booster-total-ada-6-jenis-vaksin-covid-19-yang-dipakai-di-indonesia/
- Febriani. (2021). Titer Antibodi Covid-19 : Pengertian dan Fungsinya. ciputrahospital.com. https://ciputrahospital.com/titer-antibodi-covid-19-pengertian-dan-fungsinya/
- Gobbi, F., Buonfrate, D., Moro, L., Rodari, P., Piubelli, C., Caldrer, S., Riccetti, S., Sinigaglia, A., & Barzon, L. (2021). Antibody response to the bnt162b2 mrna covid-19 vaccine in subjects with prior sars-cov-2 infection. Viruses, 13(3), 21–22. https://doi.org/10.3390/v13030422
- Halodoc.com. (2021). Waktu yang Tepat untuk Lakukan Tes Imunologi. halodoc.com. https://www.halodoc.com/artikel/kapan-waktu-yang-tepat-untuk-lakukan-tes-imunologi
- Hanie, D. (2021). Cek Kekebalan Tubuh Melalui Tes Antibodi Kuantitatif SARS-CoV 2. Primaya Hospital Group, 1–7. https://primayahospital.com/press-release/cek-kekebalan-tubuh/
- Heise, G. (2021). Berapa Total Antibodi agar Kebal terhadap Virus Corona ? 1–6.
- Irsan, A., Mardhia, & Rialita, A. (2022). ARTIKEL PENELITIAN Konsistensi Respon Imun Humoral ( IgG ) SARS-CoV-2 Pasca. Majalah Kedokteran Andalas, 45(2), 118–125.
- Kamila, N. R. (2022). Capaian Vaksin Booster Covid-19 di Indonesia Alami Stagnasi. rdk.fidkom.uinjkt.ac.id. https://rdk.fidkom.uinjkt.ac.id/index.php/2022/07/11/capaian-vaksin-booster-covid-19-di-indonesia-alami-stagnasi/
- Keluarga, M. (2022). Artikel Fungsi dan Prosedur Tes Serologi Antibodi Kuantitatif COVID-. www.mitrakeluarga.com. https://www.mitrakeluarga.com/artikel/artikel-kesehatan/serologi-antibodi-kuantitatif
- Kemenkes RI. (2021). 4 Manfaat Vaksin Covid-19 yang Wajib Diketahui. Kementerian Kesehatan RI, 021, 5223017. http://upk.kemkes.go.id/new/4-manfaat-vaksin-covid-19-yang-wajib-diketahui
- Kholidiyah, D., Sutomo, & N, K. (2021). Hubungan Persepsi Masyarakat Tentang Vaksin Covid-19 Dengan Kecemasan Saat Akan Menjalani Vaksinasi Covid-19. Jurnal Keperawatan.
- Lestari, E., Kurniasari, A., & Fristiani, B. (2022). MUNCULNYA Ig M DAN Ig G TERHADAP KADAR NLR PADA PASIEN SUSPEK COVID 19. 1, 12–15.
- Luminturahardjo, W. (2021). Peranan Probiotik dalam Penanganan Infeksi. CDK, 48(5).
- Masnun, M. A., Sulistyowati, E., & Ronaboyd, I. (2021). PELINDUNGAN HUKUM ATAS VAKSIN COVID-19 DAN TANGGUNG JAWAB NEGARA PEMENUHAN VAKSIN DALAM MEWUJUDUKAN NEGARA KESEJAHTERAAN. DiH: Jurnal Ilmu Hukum, 17(1). https://doi.org/10.30996/dih.v17i1.4325
- Matula, Z., Gönczi, M., Bekő, G., Kádár, B., Ajzner, É., Uher, F., & Vályi-Nagy, I. (2022). Antibody and T Cell Responses against SARS-CoV-2 Elicited by the Third Dose of BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) Vaccines Using a Homologous or Heterologous Booster Vaccination Strategy. Vaccines, 10(4), 1–12. https://doi.org/10.3390/vaccines10040539
- Nurhanisah, Y. (2021). Vak sin Booster dan Dosis Ketiga , Sama atau Beda ? indonesiabaik.id. https://indonesiabaik.id/infografis/vaksin-booster-dan-dosis-ketiga-sama-atau-beda
- Pascarella, G., Strumia, A., Piliego, C., Bruno, F., Del Buono, R., Costa, F., Scarlata, S., & Agrò, F. E. (2020). COVID-19 diagnosis and management: a comprehensive review. Journal of Internal Medicine, 288(2), 192–206. https://doi.org/10.1111/joim.13091
- Pusparini, P. (2020). Tes serologi dan polimerase chain reaction (PCR) untuk deteksi SARS-CoV-2/COVID-19. Jurnal Biomedika dan Kesehatan, 3(2), 46–48. https://doi.org/10.18051/jbiomedkes.2020.v3.46-48
- Rotty, I., Kristanto, E. G., Sekeon, S., Ekawardani, N., & Liwe, H. R. (2022). Formation of SARS-CoV-2 Specific Antibody after vaccination. e-CliniC, 10(1). https://doi.org/10.35790/ecl.v10i1.37193
- Salmaa. (2017). Penelitian Deskriptif. penerbitdepublish.com. https://penerbitdeepublish.com/penelitian-deskriptif/
- Shekhar, R., Garg, I., Pal, S., Kottewar, S., & Sheikh, A. B. (2021). COVID-19 vaccine booster: To boost or not to boost. In Infectious Disease Reports (Vol. 13, Nomor 4). https://doi.org/10.3390/idr13040084
- Sunur, I. C. (2021). Pemeriksaan Antibodi Setelah Vaksinasi COVID-19 Tidak Diperlukan.